Hi-Tech Pharma Enters Oversold Territory - Tale of the Tape

By
A A A

Hi-Tech Pharmacal Co. 's ( HITK ) share price has entered into oversold territory with a stochastic value of 16.140. The Zacks Consensus Estimate on the company's earnings for April 2012 increased by 29 cents over the past week to $3.61 per share. Hi-Tech Pharmacal Co. is a Zacks #1 Rank ("Strong Buy") company.


 
HI TECH PHARMA ( HITK ): Free Stock Analysis Report
 
Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: HITK

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

The Danger of Small ETFs
The Danger of Small ETFs            

Stocks

Referenced

Most Active by Volume

2,002,118
  • $47.8699 ▼ 0.62%
1,807,109
  • $38.6375 ▲ 2.24%
1,697,075
  • $16.35 ▲ 0.12%
1,667,823
  • $75.2498 ▼ 0.94%
1,229,735
  • $29.50 ▲ 0.99%
1,226,535
  • $101.04 ▲ 0.15%
1,022,103
  • $3.55 ▼ 0.28%
967,004
  • $5.83 ▲ 1.04%
As of 8/27/2014, 09:34 AM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com